ACCRETION PHARMACEUTICALS
Sector : Pharmaceuticals and health care | Smallcap | NSE
Here's the live share price of Accretion Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
5.00₹ 4.40
As on Dec 5, 2025, 2:59 PM IST
Accretion Pharmaceuticals Price Performance
Today's LowToday's High
₹88.00₹92.45
₹92.45
52 Weeks' Low52 Weeks' High
₹53.80₹102.50
₹92.45
Open Price
₹88.00
Prev. Close
₹88.05
Volume
14,400
Over the last 5 years, the share price of Accretion Pharmaceuticals has gained 2.19% CAGR. Over the past year, the corresponding return has been 11.45%.
Accretion Pharmaceuticals’s current P/E of 11.32x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Accretion Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Accretion Pharmaceuticals | -8.51 | 67.63 | 49.11 | 44.23 | 11.45 | 3.68 | 2.19 |
| Sun Pharmaceutical Industries | -1.63 | 6.87 | 13.06 | 7.05 | -0.65 | 20.12 | 25.35 |
| Divi's Laboratories | -0.52 | -6.4 | 7.22 | -2.8 | 5.69 | 24.13 | 11.63 |
| Torrent Pharmaceuticals | 1.71 | 6.49 | 5.73 | 20.45 | 12.57 | 32.69 | 22.98 |
| Cipla | -0.86 | 1.11 | -2.27 | 1.91 | 1.33 | 10.83 | 14.45 |
| Dr. Reddy's Laboratories | 1.05 | 5.54 | 0.31 | -1.44 | 2.59 | 12.39 | 4.81 |
| Lupin | 0.48 | 6.99 | 7.62 | 4.86 | -1.55 | 39.53 | 16.68 |
| Zydus Lifesciences | -1.38 | -0.77 | -8.32 | -2.74 | -4.96 | 31 | 14.51 |
| Mankind Pharma | -2.33 | -4.79 | -13.8 | -6.81 | -15.94 | 15.62 | 9.1 |
| Aurobindo Pharma | -1 | 6.47 | 16.31 | 4.73 | -2.35 | 37.63 | 5.94 |
| Alkem Laboratories | -0.44 | 0.29 | 6.12 | 16.86 | 0.28 | 21.96 | 14.14 |
| Abbott India | -4.24 | -2.22 | -7.54 | -9.13 | -0.83 | 12.81 | 13.5 |
| Glenmark Pharmaceuticals | 0.64 | 8.19 | -4.54 | 23.59 | 26.81 | 65.03 | 29.78 |
| Laurus Labs | -0.88 | 4.34 | 16.08 | 59.57 | 73.76 | 34.46 | 25.22 |
| Biocon | -1.81 | 1.54 | 7.55 | 18.32 | 4.24 | 11.86 | -2.79 |
| GlaxoSmithKline Pharmaceuticals | -0.78 | -2.15 | -7.97 | -26.45 | 7.06 | 23.85 | 10.45 |
| Ipca Laboratories | 0.26 | 11.66 | 9.13 | 5.12 | -2.44 | 19.03 | 5.59 |
| Anthem Biosciences | 3.51 | -5.69 | -20.83 | -10.05 | -10.05 | -3.47 | -2.1 |
| Ajanta Pharma | 3.08 | 2.76 | 0.98 | 2.4 | -9.42 | 27.96 | 18.71 |
| Gland Pharma | -0.76 | -8.02 | -7.71 | 6.9 | -4.79 | -0.04 | -5.79 |
Over the last one year, Accretion Pharmaceuticals has gained 11.45% compared to peers like Sun Pharmaceutical Industries (-0.65%), Divi's Laboratories (5.69%), Torrent Pharmaceuticals (12.57%). From a 5 year perspective, Accretion Pharmaceuticals has underperformed peers relative to Sun Pharmaceutical Industries (25.35%) and Divi's Laboratories (11.63%).
Accretion Pharmaceuticals Financials
Accretion Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 91.77 | 87.89 |
| 10 | 85.97 | 85.62 |
| 20 | 75.93 | 79.54 |
| 50 | 65.39 | 70.76 |
| 100 | 63.77 | 68.05 |
| 200 | 44.35 | 0 |
Accretion Pharmaceuticals Share Holding Pattern
In the latest quarter, Accretion Pharmaceuticals saw a rise in promoter holding to 73.50%, while DII stake decreased to 0.00%, FII holding fell to 1.16%, and public shareholding moved up to 25.33% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Accretion Pharmaceuticals Corporate Actions
There's no recent Announcement information to show for the company. You may visit the Accretion Pharmaceuticals fact sheet for more information
About Accretion Pharmaceuticals
Accretion Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 18/12/2012 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is U21004GJ2023PLC146545 and registration number is 146545. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 57.38 Cr. and Equity Capital is Rs. 8.17 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address29 Xcelon Ind Park 1, B/H, Intas Pharmaceuticals, Ahmedabad Gujarat 382213
- Contact
Management
- Mr. Vivek Ashok Kumar PatelManaging Director
- Mr. Mayur Popatlal SojitraDirector
- Mr. Harshad Nanubhai RathodDirector & CEO
- Mr. Hardik Mukundbhai PrajapatiDirector
- Mr. Chand Rameshbhai KanabarIndependent Director
- Mr. Vijay Bharatbhai AnadkatIndependent Director
- Ms. Grishma A ShewaleIndependent Director
FAQs on Accretion Pharmaceuticals Share Price
What is the share price of Accretion Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Accretion Pharmaceuticals is ₹92.45 as on Dec 05, 2025.
What kind of stock is Accretion Pharmaceuticals?
The Accretion Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the NSE.
What is the Market Cap of Accretion Pharmaceuticals?
The market cap of Accretion Pharmaceuticals is ₹102.77 Cr as on Dec 05, 2025.
What are today's High and Low prices of Accretion Pharmaceuticals?
Today’s highest and lowest price of Accretion Pharmaceuticals are ₹92.45 and ₹88.00.
What are the 52 Week High and 52 Week Low of Accretion Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Accretion Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Accretion Pharmaceuticals is ₹102.50 and 52-week low of Accretion Pharmaceuticals is ₹53.80 as on Dec 05, 2025.
How has the Accretion Pharmaceuticals performed historically in terms of returns?
The Accretion Pharmaceuticals has shown returns of 5.0% over the past day, 67.63% for the past month, 49.11% over 3 months, 11.45% over 1 year, 3.68% across 3 years, and 2.19% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Accretion Pharmaceuticals?
P/E ratio of and PB ratio of Accretion Pharmaceuticals are 11.32 and 6.22 on Dec 05, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse